This will be an open label multicenter study of the safety and efficacy of an active implantable vagal nerve stimulation (VNS) device in patients with rheumatoid arthritis. Patients who complete study SPM-005 will be enrolled in this study at the time of the last visit of the preceding study.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01552538?cond=%22Arthritis%22&lup_s=01/29/2014&lup_d=30
